DANIEL LORRAIN plan to sell securities of Contineum Therapeutics, Inc. under Form 144

DANIEL LORRAIN filed Form 144 to notify SEC of plan to sell 4170 units of Contineum Therapeutics, Inc. securities around 2025-12-23, with aggregate market value of $51,124.20. The total outstanding units is 23099173.0. The amount planned to be sold represents 0.02% of total outstanding units;